FR607M - - Google Patents

Info

Publication number
FR607M
FR607M FR837423A FR837423A FR607M FR 607 M FR607 M FR 607M FR 837423 A FR837423 A FR 837423A FR 837423 A FR837423 A FR 837423A FR 607 M FR607 M FR 607M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837423A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR789324A external-priority patent/FR1268445A/fr
Application granted granted Critical
Publication of FR607M publication Critical patent/FR607M/fr
Application filed filed Critical
Priority to FR837423A priority Critical patent/FR607M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR837423A 1958-03-13 1961-08-31 Active FR607M (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837423A FR607M (enExample) 1958-03-13 1961-08-31

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72110458A 1958-03-13 1958-03-13
FR789324A FR1268445A (fr) 1958-03-13 1958-03-13 Dérivés de la pyrrolo [2. 3-d] pyrimidine et leur préparation
FR837423A FR607M (enExample) 1958-03-13 1961-08-31

Publications (1)

Publication Number Publication Date
FR607M true FR607M (enExample) 1961-06-19

Family

ID=24896553

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837423A Active FR607M (enExample) 1958-03-13 1961-08-31

Country Status (3)

Country Link
ES (1) ES247857A1 (enExample)
FR (1) FR607M (enExample)
GB (2) GB915304A (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311628A (en) * 1965-03-09 1967-03-28 Bristol Myers Co Derivatives of pyrrolo [2, 3-d] pyrimidine
CH592668A5 (enExample) * 1973-10-02 1977-10-31 Delalande Sa
DK0682027T3 (da) * 1994-05-03 1998-05-04 Ciba Geigy Ag Pyrrolopyrimidinderivater med antiproliferativ virkning
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
AU763658B2 (en) * 1998-06-02 2003-07-31 Osi Pharmaceuticals, Inc. Pyrrolo(2,3d)pyrimidine compositions and their use
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
PT1087970E (pt) * 1998-06-19 2004-06-30 Pfizer Prod Inc Compostos pirrolo¬2,3-d|pirimidina
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
EP1235830B1 (en) 1999-12-10 2004-01-02 Pfizer Products Inc. PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
DK1450811T3 (da) 2001-11-30 2010-02-15 Osi Pharm Inc Forbindelser specifikke af adenosin A1- og A3-receptorer og anvendelser heraf
DE60236458D1 (de) 2001-12-20 2010-07-01 Osi Pharm Inc Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
DE60235500D1 (de) 2001-12-20 2010-04-08 Osi Pharm Inc Selektive pyrimidin-a2b-antagonistenverbindungen, ihre synthese und verwendung
WO2004047843A1 (en) 2002-11-26 2004-06-10 Pfizer Products Inc. Method of treatment of transplant rejection
US20070208053A1 (en) * 2006-01-19 2007-09-06 Arnold Lee D Fused heterobicyclic kinase inhibitors
SI2384326T1 (sl) 2008-08-20 2014-06-30 Zoetis Llc Pirolo(2,3-d)pirimidinske spojine
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Also Published As

Publication number Publication date
GB915304A (en) 1963-01-09
GB915303A (en) 1963-01-09
ES247857A1 (es) 1959-08-16

Similar Documents

Publication Publication Date Title
AT214638B (enExample)
AT221043B (enExample)
AT217439B (enExample)
AT215747B (enExample)
AT213908B (enExample)
AT213446B (enExample)
AT216227B (enExample)
AT215751B (enExample)
AT219815B (enExample)
AT219868B (enExample)
AT214270B (enExample)
AT214348B (enExample)
AT213631B (enExample)
AT213670B (enExample)
AT213558B (enExample)
AT213557B (enExample)
AT213472B (enExample)
AT216612B (enExample)
AT216749B (enExample)
AT216771B (enExample)
AT216803B (enExample)
AT216831B (enExample)
AT213337B (enExample)
AT217982B (enExample)
AT215738B (enExample)